~~<i id='91C518B3A9'><strike id='91C518B3A9'><tt id='91C518B3A9'><pre id='91C518B3A9'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

author：explore 2025-09-13 16:54:26 Page View：5

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Discs beat pads, tampons for heavy menstrual flow, new study shows
Next article： After affirmative action ruling, medical educators look to 'holistic review'

explore

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

2:08Sen.TommyTubervillespeakstoreportersintheSenatesubwayattheU.S.CapitolJuly10,2023inWashington,DC.

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Choosing scientific sides in the fight against Alzheimer's

MollyFergusonforSTATIn1906,Dr.AloisAlzheimerworkedwithapatientnamedAugustD.,awomanwithextremememoryl